Low Rectal Cancer
Showing 1 - 25 of >10,000
Rectal Tumors Trial (Registry study, no specific intervention)
Not yet recruiting
- Rectal Neoplasms
- Registry study, no specific intervention
- (no location specified)
May 21, 2023
Rectal Tumors, Low Anterior Resection Syndrome, Anastomotic Leak Trial (Parks technique, Bacon technique)
Not yet recruiting
- Rectal Neoplasms
- +3 more
- Parks technique
- Bacon technique
- (no location specified)
Jul 12, 2023
Low Rectal Cancer Trial in Hanzhou (Modified short-course radiotherapy, PD-1 antibody, Capecitabine)
Not yet recruiting
- Low Rectal Cancer
- Modified short-course radiotherapy
- +3 more
-
Hanzhou, Zhejiang, ChinaSir Run Run Shao hospital
Jul 31, 2023
Rectal Cancer, Lymph Node Cancer Metastatic Trial in Milan (ICG-guided lymphadenectomy)
Recruiting
- Rectal Cancer
- Lymph Node Cancer Metastatic
- ICG-guided lymphadenectomy
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
May 15, 2023
Rectal Cancer Trial (CapeOX + cetuximab, CapeOX + bevacizumab, radiotherapy)
Not yet recruiting
- Rectal Cancer
- CapeOX + cetuximab
- +2 more
- (no location specified)
Sep 12, 2023
Colorectal Cancer Trial (Serplulimab + FOLFOXIRI, Radiation therapy)
Not yet recruiting
- Colorectal Cancer
- Serplulimab + FOLFOXIRI
- Radiation therapy
- (no location specified)
Oct 24, 2023
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and
Not yet recruiting
- Colorectal Neoplasms
-
Beijing, Xicheng Dis, ChinaBeijing Friendship Hospital, Capital medical University
Sep 5, 2023
Rectal Cancer Trial in Fuzhou (radiation, drug, procedure)
Not yet recruiting
- Rectal Cancer
- split-course hypofraction radiotherapy
- +3 more
-
Fuzhou, Fujian, ChinaPan Chi
Jul 23, 2023
Locally Advanced Rectal Cancer Trial in Beijing (capecitabine, tislelizumab, thymalfasin)
Not yet recruiting
- Locally Advanced Rectal Cancer
- capecitabine
- +3 more
-
Beijing, China
- +1 more
Sep 21, 2023
Locally Advanced Rectal Cancer Trial in Beijing (Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor), Long-course
Recruiting
- Locally Advanced Rectal Cancer
- Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor)
- Long-course chemoradiation, without Tislelizumab (PD-1 inhibitor)
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Apr 25, 2023
Early Low Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)
Recruiting
- Early Low Rectal Cancer
- PD-1 antibody
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 9, 2023
the Value of Transanal Endoscopic ISR
Completed
- Rectal Cancer
- transanal endoscopic ISR
-
Shanghai, China
- +1 more
Jun 27, 2023
Department of Anorectal Surgery, Changhai Hospital Affiliated to Naval Medical University Trial (Laparoscopic radical resection
Not yet recruiting
- Department of Anorectal Surgery, Changhai Hospital Affiliated to Naval Medical University
- Laparoscopic radical resection of low rectal cancer with transanal specimens
- (no location specified)
Aug 14, 2022
Total Mesorectal Excision, Rectal Tumors, Robotic Surgical Procedures Trial in Changchun (Robotic-assisted total mesorectal
Not yet recruiting
- Total Mesorectal Excision
- +3 more
- Robotic-assisted total mesorectal excision
- laparoscopic-assisted total mesorectal excision
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Oct 23, 2023
Neoadjuvant Chemoradiation Therapy, Rectal Cancer, Immunotherapy Trial in Shanghai (xintilimab injection, Control)
Recruiting
- Neoadjuvant Chemoradiation Therapy
- +3 more
- xintilimab injection
- Control
-
Shanghai, Shanghai, ChinaDepartment of Colorectal Surgery in Changhai Hospital
Aug 5, 2022
Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer
Completed
- Rectal Cancer
- total mesorectal excision
- (no location specified)
Aug 9, 2022
Rectal Cancer Trial in Beijing, Shanghai, Chengdu (Dissection of the No.253 lymph node, Omitting the dissection of the No.253
Not yet recruiting
- Rectal Cancer
- Dissection of the No.253 lymph node
- Omitting the dissection of the No.253 lymph node
-
Beijing, Beijing, China
- +6 more
Nov 27, 2023
Rectal Cancer Trial in Changchun (stoma drainage reinfusion, Standard of Care - No Return of Stoma Drain)
Not yet recruiting
- Rectal Cancer
- stoma drainage reinfusion
- Standard of Care - No Return of Stoma Drain
-
Changchun, Jilin, ChinaJilin University First Hospital
Jul 14, 2022
Chemo Effect, Rectal Cancer Trial in Guangzhou (Radical total mesorectal excision, Salavge Adjuvant Chemoradiotherapy)
Recruiting
- Chemotherapy Effect
- Rectal Cancer
- Radical total mesorectal excision
- Salavge Adjuvant Chemoradiotherapy
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Sep 12, 2023
Rectal Cancer Trial in Montpellier (TME with LAR)
Recruiting
- Rectal Cancer
- TME with LAR
-
Montpellier, FranceCentre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
Nov 16, 2022
Colorectal Cancer, Colorectal Tumors Malignant, Intestinal Tumors, Malignant Trial in Shanghai (Ileostomy, Transverse colostomy)
Recruiting
- Colorectal Cancer
- +2 more
- Ileostomy
- Transverse colostomy
-
Shanghai, ChinaFudan University Shanghai Cancer Center
May 2, 2023
Chemotherapy Combined With High-dose Radiotherapy for Low Rectal
Recruiting
- Rectal Cancer
- Magnetic resonance guided radiotherapy
- Chemotherapy
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 9, 2022
Ileostomy - Stoma, Rectal Cancer, Microbial Disease Trial in Shanghai (MIYAIRI 588)
Recruiting
- Ileostomy - Stoma
- +3 more
- MIYAIRI 588
-
Shanghai, ChinaHuashan hospital
Mar 12, 2023
Rectal Cancer Trial in Taoyuan City
Recruiting
- Rectal Cancer
-
Taoyuan City, Kwei-Shan Dist., TaiwanChung Gung University
Aug 24, 2023
Rectal Cancer Trial in Umeå (Defunctioning left-sided loop colostomy)
Recruiting
- Rectal Cancer
- Defunctioning left-sided loop colostomy
-
Umeå, SwedenUmeå University Hospital
Nov 20, 2023